Papillomavirus screening in cervical cell samples using dual-label dot-blot analysis.
The presence of human papillomavirus (HPV) in cervical cells is closely related to the development of cervical carcinoma. Detection of virus may be by Southern blot, dot blot or the highly sensitive polymerase chain reaction. Whatever method is employed, there are problems of false negatives due to poor clinical samples in which the DNA may be degraded or is absent altogether. Here we describe a new method of dual labelling for dot blots using a 32P-labelled probe for HPV and a 35S-labelled probe for human actin genes. The samples were counted on a Beta-plate flat-bed scintillation counter and the data analysed to separate the activities of the two isotopes. The counts from the actin probe show whether human DNA is present or not and false negatives from this cause may thereby be eliminated. The counts due to HPV when compared with those for actin give a quantitative measure of HPV abundance for the particular sample and this may have clinical relevance.
Potter
C G
CG
Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Headington, Oxford, U.K.
Cooper
K
K
Stickland
J E
JE
Ramshaw
A L
AL
McGee
J O
JO
D000199:Actins / Q000235:genetics; D002584:Cervix Uteri / Q000382:microbiology*; D004247:DNA / Q000032:analysis; D005260:Female; D006801:Humans; D015151:Immunoblotting / Q000379:methods*; D027383:Papillomaviridae / Q000302:isolation & purification*; D010761:Phosphorus Radioisotopes; D013462:Sulfur Radioisotopes; D002583:Uterine Cervical Neoplasms / Q000382:microbiology*
D000199:Actins; D010761:Phosphorus Radioisotopes; D013462:Sulfur Radioisotopes; D004247:DNA